Ensuring the safety and efficacy of antibody-based therapeutics is crucial in biotherapeutic manufacturing. Accurate testing for ligand leakage from affinity resins is a key part of this process, ensuring compliance with regulatory standards.
Our new VH3 ligand ELISA kit – the latest addition to Cytiva’s impurity portfolio – is the only commercial solution dedicated to testing VH3 ligand leakage. This kit is essential for users of MabSelect™ VH3 resin in process development and production, providing a comprehensive and reliable solution.
